Allogene Therapeutics Q4 2024 Earnings Call Transcript: Insights from the Innovative Cell Therapy Company
Allogene Therapeutics: Insights from the Q4 2024 Earnings Conference Call On March 13, 2025, Allogene Therapeutics, Inc. (NASDAQ: ALLO) held its Q4 2024 earnings conference call. The call was led by Christine Cassiano, EVP and Chief Corporate Affairs & Brand Strategy Officer, and was joined by Co-Founder, President, CEO & Director, David Chang; EVP, Research…